[Comment] Aspirin for secondary prevention of cardiovascular disease
Robert A Byrne, Róisín Colleran | thelancet.com | 2020-05-09
The antithrombotic efficacy of low-dose aspirin is well established. Its primary clinical effect is mediated by inhibition of platelet cyclooxygenase-1, which reduces thromboxane A2 formation and inhibits platelet aggregation. Over the course of recent decades, aspirin administration has shown a favourable risk–benefit ratio for reducing the risk of adverse events in patients with known atherosclerotic disease.1,2 By contrast, in patients without known atherosclerotic disease who are at risk of cardiovascular disease, the overall benefits of aspirin in terms of primary prevention of atherothrombotic events…
thelancet.com/journals/lancet/article/PIIS0140-6736(20)30799-6/fulltext?rss=yes

Without an Economic Recovery, Argentina Cannot Repay Its Debt
Lara Merling | counterpunch.org | 2020-05-08
For those following Argentina's debt saga, the current situation might seem eerily familiar: after the implosion of an IMF program, Argentina finds itself at the brink of default, with a debt burden, denominated in foreign currencies, that it simply cannot pay. In contrast with Argentina's default in 2001, when it reached agreements with most of…
counterpunch.org/2020/05/08/without-an-economic-recovery-argentina-cannot-repay-its-debt/